Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 11371030 Modified Cas9 protein and use thereof
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Patent
Current Assignee
The University of Tokyo Edge Capital
Date Filed
May 31, 2018
Date of Patent
June 28, 2022
Patent Applicant
The University of Tokyo Edge Capital
Patent Application Number
16617498
Patent Citations
US Patent 10202589 Engineered CRISPR-Cas9 nucleases with altered PAM specificity
US Patent 10479982 Engineered CRISPR-Cas9 nucleases with altered PAM specificity
Patent Jurisdiction
United States Patent and Trademark Office
Patent Number
11371030
Patent Primary Examiner
Delia M. Ramirez
CPC Code
C12N 15/09
C12N 9/22
C07K 2319/50
C07K 2319/21
C12N 15/113
Find more entities like US Patent 11371030 Modified Cas9 protein and use thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
SUBSCRIBE